A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide

NCT05771883 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

B-cell Non-Hodgkin's Lymphoma

Interventions

DRUG: IMM0306
DRUG: Lenalidomide capsule

Sponsor

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.